Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline

Summary

Quotient Sciences and Acesion Pharma announced a collaboration using AI-enhanced technology to accelerate formulation development for atrial fibrillation treatments. The partnership aims to compress early clinical decision-making through improved drug formulation identification.